🇺🇸 FDA
Patent

US 10006924

Method for differentially diagnosing ACTH-dependent cushing's syndrome

granted A61KA61K31/4745A61K31/567

Quick answer

US patent 10006924 (Method for differentially diagnosing ACTH-dependent cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4745, A61K31/567, A61K31/573